AstraZeneca and Daiichi become the first companies to have developed a therapy aimed at treating metastatic breast cancer that manifests low level of HER2, a new category that was once classified under HER2-negative. AstraZeneca’s Enhertu has received FDA’s approval as the trial shows that it cuts down the risk of tumour progression by 50%. Enhertu shows various benefits after one session of chemotherapy of metastatic tumour.
Read More from FiercePharma
According to Business Wire, global Healthcare Industry will be worth $12T by 2022. Healthcare is vast and highly fragmented with a mix of public and private players. It comprises patients and healthcare providers such as hospitals, pharmaceuticals, and related life sciences.
Digitisation and Post-Covid world are set to transform the healthcare industry in the coming decade. Our weekly business newsletter covers innovations and disruptions in the Healthcare industry with global coverage.
HealthGeniuses is managed by IndustryGeniuses (A place where industries meet innovation). We are rolling out content platforms for the world’s hottest industries such as Food & Grocery Retail, Consumer Goods and Healthcare. For each of these key industries, we support Tech Startups and Industry Disruptors as they roll out next generation digital initiatives.
IndustryGeniuses team brings practical domain knowledge of working with 300+ tech startups and brands over the past decade.